Peter J. Allen
#144,235
Most Influential Person Now
Peter J. Allen's AcademicInfluence.com Rankings
Peter J. Allenphilosophy Degrees
Philosophy
#7685
World Rank
#10931
Historical Rank
Logic
#4726
World Rank
#6050
Historical Rank

Download Badge
Philosophy
Peter J. Allen's Degrees
- Doctorate Medicine Stanford University
Why Is Peter J. Allen Influential?
(Suggest an Edit or Addition)Peter J. Allen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After (2017) (2307)
- Detection and localization of surgically resectable cancers with a multi-analyte blood test (2018) (1556)
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer (2017) (720)
- Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development (2011) (711)
- Merkel cell carcinoma: prognosis and treatment of patients from a single institution. (2005) (683)
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. (2016) (616)
- Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. (2018) (538)
- Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways (2011) (535)
- Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. (2010) (452)
- Impact of steatosis on perioperative outcome following hepatic resection (2003) (413)
- European evidence-based guidelines on pancreatic cystic neoplasms (2018) (401)
- Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers (2017) (387)
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients (2015) (354)
- A combination of molecular markers and clinical features improve the classification of pancreatic cysts. (2015) (339)
- Pasireotide for postoperative pancreatic fistula. (2014) (335)
- Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma (2017) (316)
- Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases (2003) (301)
- Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades (2011) (297)
- Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone. (2016) (260)
- Preoperative Predictors for Complications after Pancreaticoduodenectomy: Impact of BMI and Body Fat Distribution (2007) (258)
- Surgical management of Merkel cell carcinoma. (1999) (257)
- PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. (2008) (246)
- Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas (2015) (242)
- Ablation of perivascular hepatic malignant tumors with irreversible electroporation. (2012) (236)
- Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. (2007) (235)
- Pancreatic Adenocarcinoma: The Actual 5-Year Survivors (2008) (229)
- An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. (2011) (222)
- Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. (2002) (220)
- Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? (2012) (216)
- BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. (2009) (208)
- A Selective Approach to the Resection of Cystic Lesions of the Pancreas: Results From 539 Consecutive Patients (2006) (206)
- Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. (2011) (205)
- Serum Biomarker Panels for the Detection of Pancreatic Cancer (2011) (194)
- Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas: A Clinicopathologic Analysis of 44 Cases (2014) (193)
- Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. (2016) (188)
- The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. (2012) (180)
- Laparoscopic Versus Open Subtotal Gastrectomy for Adenocarcinoma: A Case–Control Study (2009) (177)
- Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer (2007) (175)
- Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. (2008) (175)
- Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. (2010) (175)
- Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches. (2015) (174)
- Accurate Staging for Gallbladder Cancer: Implications for Surgical Therapy and Pathological Assessment (2011) (171)
- Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma (2008) (170)
- Solid Pseudopapillary Tumors of the Pancreas. Clinical Features, Surgical Outcomes, and Long-Term Survival in 45 Consecutive Patients from a Single Center (2011) (165)
- Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. (2014) (164)
- Feasibility and Yield of Screening in Relatives From Familial Pancreatic Cancer Families (2011) (158)
- Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. (2007) (156)
- Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? (2015) (155)
- Five Hundred Patients With Merkel Cell Carcinoma Evaluated at a Single Institution (2011) (153)
- Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms (2018) (151)
- A Retrospective Comparison of Microwave Ablation vs. Radiofrequency Ablation for Colorectal Cancer Hepatic Metastases (2014) (149)
- Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. (2016) (148)
- Operative Drainage Following Pancreatic Resection: Analysis of 1122 Patients Resected Over 5 Years at a Single Institution (2013) (144)
- Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. (2005) (141)
- Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. (2019) (141)
- Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. (2015) (140)
- Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype (2017) (138)
- Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. (2009) (137)
- Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? (2007) (137)
- Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study (2016) (135)
- GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. (2015) (134)
- FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma (2015) (131)
- Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy (2014) (130)
- Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma (2010) (129)
- KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases (2014) (126)
- A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma (2014) (122)
- Laparoscopic versus Open Liver Resection: A Matched-Pair Case Control Study (2009) (122)
- Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients (2003) (117)
- Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone (2016) (117)
- Actual 10‐year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? (2018) (116)
- Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. (2015) (113)
- Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. (2011) (111)
- A Matched Case-Control Study of Preoperative Biliary Drainage in Patients with Pancreatic Adenocarcinoma: Routine Drainage Is Not Justified (2009) (109)
- Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway. (2010) (108)
- Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma (2016) (108)
- Cyst Fluid Interleukin-1β (IL1β) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2011) (108)
- Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma (2001) (107)
- Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. (2008) (105)
- Invasive Carcinoma Arising in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Matched Control Study with Conventional Pancreatic Ductal Adenocarcinoma (2011) (105)
- Relationship Between Intraoperative Fluid Administration and Perioperative Outcome After Pancreaticoduodenectomy: Results of a Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared With Standard Intraoperative Management (2010) (103)
- Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. (2011) (101)
- Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer (2011) (101)
- Long‐term outcomes following microwave ablation for liver malignancies (2015) (99)
- A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (99)
- Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation (2013) (97)
- Polypoid lesions of the gallbladder: diagnosis and followup. (2009) (97)
- GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling (2014) (97)
- Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2010) (95)
- A multimodality test to guide the management of patients with a pancreatic cyst (2019) (94)
- Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis. (2017) (92)
- Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2015) (92)
- Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. (2016) (91)
- Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. (2015) (90)
- Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection (2016) (90)
- Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. (2012) (88)
- Defining Surgical Indications for Type I Gastric Carcinoid Tumor (2009) (88)
- Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic Metastases (2009) (88)
- Robotic Liver Resection: A Case-Matched Comparison (2016) (88)
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. (2019) (86)
- Biobanking of Human Pancreas Cancer Tissue: Impact of Ex-Vivo Procurement Times on RNA Quality (2010) (85)
- Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium (2018) (85)
- Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis (2018) (85)
- Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. (2013) (84)
- Attenuation of the Retinoblastoma Pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk4/Cdk6 (2012) (83)
- Is Port Site Resection Necessary in the Surgical Management of Gallbladder Cancer? (2012) (83)
- Single-incision laparoscopic liver resection (2011) (82)
- Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases (2018) (82)
- Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated (2017) (82)
- Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma (2012) (80)
- Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. (2014) (79)
- Biliary Self-Expandable Metal Stents Do Not Adversely Affect Pancreaticoduodenectomy (2013) (79)
- Predicting Dysplasia and Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Development of a Preoperative Nomogram (2013) (79)
- Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients (2016) (78)
- Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. (2013) (77)
- The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma (2006) (75)
- Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract (2009) (74)
- Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma (2017) (74)
- Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. (2013) (74)
- Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. (2017) (74)
- Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. (2010) (74)
- The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas (2006) (73)
- Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection (2015) (73)
- Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response (2011) (72)
- T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. (2010) (72)
- Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. (2016) (70)
- Endoscopic ultrasound-guided transmural drainage of postoperative pancreatic collections. (2014) (70)
- Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. (2018) (70)
- Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study (2014) (69)
- The role of laparoscopic staging in patients with incidental gallbladder cancer. (2011) (69)
- Failure Patterns in Resected Pancreas Adenocarcinoma: Lack of Predicted Benefit to SMAD4 Expression (2013) (69)
- Evaluation of Cyst Fluid CEA Analysis in the Diagnosis of Mucinous Cysts of the Pancreas (2010) (68)
- The surgical management of metastatic melanoma (2002) (68)
- CT radiomics to predict high‐risk intraductal papillary mucinous neoplasms of the pancreas (2018) (68)
- The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer (2018) (68)
- Value of Frozen-Section Analysis of Sentinel Lymph Nodes for Primary Cutaneous Malignant Melanoma (2002) (67)
- Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors (2012) (67)
- Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases (2014) (67)
- Allergies, obesity, other risk factors and survival from pancreatic cancer (2010) (67)
- Management of peripancreatic fluid collections following partial pancreatectomy: a comparison of percutaneous versus EUS-guided drainage (2013) (66)
- Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors (2014) (65)
- Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases (2017) (64)
- Updated long‐term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy (2016) (64)
- The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes (2016) (63)
- The management of variant arterial anatomy during hepatic arterial infusion pump placement (2002) (63)
- The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study (2017) (62)
- Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. (2015) (61)
- Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients (2017) (60)
- Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors (2012) (60)
- Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. (2014) (59)
- Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified? (2012) (59)
- Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome (2017) (58)
- Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome (2012) (58)
- Goal-Directed Fluid Therapy Using Stroke Volume Variation for Resuscitation after Low Central Venous Pressure-Assisted Liver Resection: A Randomized Clinical Trial. (2015) (58)
- Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results (2011) (58)
- Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (⩽20-mm Invasive Component): A Multi-institutional Analysis (2016) (57)
- Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort (2017) (55)
- Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer (2016) (55)
- Desmoid tumors of the chest wall. (1999) (54)
- Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. (2013) (53)
- Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases (2013) (53)
- The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. (2012) (53)
- Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. (2010) (53)
- Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma (2017) (52)
- Predicting recurrence patterns after resection of hepatocellular cancer. (2014) (52)
- Pancreatic Cyst Fluid Protein Expression Profiling for Discriminating Between Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm (2009) (52)
- Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma (2016) (51)
- Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. (2017) (51)
- Comparison Between Perioperative and Postoperative Chemotherapy After Potentially Curative Hepatic Resection for Metastatic Colorectal Cancer (2013) (50)
- Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation (2019) (50)
- Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. (2018) (49)
- Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2016) (49)
- Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease (2011) (48)
- Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. (2013) (48)
- Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma (2012) (48)
- Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential (2018) (48)
- Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma (2017) (47)
- Management of hepatocellular adenoma: comparison of resection, embolization and observation. (2013) (47)
- CXCR4 Expression Predicts Patient Outcome and Recurrence Patterns after Hepatic Resection for Colorectal Liver Metastases (2012) (46)
- Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. (2015) (45)
- Tumor MHC Class I Expression Improves the Prognostic Value of T-cell Density in Resected Colorectal Liver Metastases (2014) (45)
- Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma (2021) (45)
- Current management of cystic neoplasms of the pancreas. (2008) (45)
- Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. (2008) (44)
- Readmission After Pancreatic Resection: Causes and Causality Pattern (2014) (44)
- Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer (2017) (44)
- Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance (2011) (44)
- Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy (2016) (44)
- American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. (2014) (44)
- Patterns of Recurrence After Ablation of Colorectal Cancer Liver Metastases (2012) (43)
- Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes (2015) (43)
- Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage (2015) (43)
- Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. (2014) (43)
- Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution (2017) (43)
- Detailed Pathologic Characteristics of the Primary Colorectal Tumor Independently Predict Outcome after Hepatectomy for Metastases (2012) (43)
- Hepatic Pedicle Clamping During Hepatic Resection for Colorectal Liver Metastases: No Impact on Survival or Hepatic Recurrence (2012) (42)
- Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases (2015) (42)
- Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease (2015) (41)
- Internal hernia after gastrectomy for cancer with Roux-Y reconstruction. (2013) (41)
- Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. (2015) (40)
- ID1 mediates escape from TGF-β tumor suppression in pancreatic cancer. (2019) (40)
- Minimally invasive distal pancreatectomy. (2017) (40)
- Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution (2013) (38)
- Positive Postoperative CEA is a Strong Predictor of Recurrence for Patients After Resection for Colorectal Liver Metastases (2015) (37)
- Specific Glycoforms of MUC5AC and Endorepellin Accurately Distinguish Mucinous from Nonmucinous Pancreatic Cysts* (2013) (37)
- Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging. (2013) (37)
- Colon sentinel lymph node mapping: practical surgical applications. (2005) (37)
- Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab (2014) (36)
- Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas (2017) (36)
- The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial (2017) (36)
- A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases (2016) (35)
- Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial (2016) (35)
- Current status of hepatic resection. (2003) (35)
- Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis. (2013) (35)
- Impact of pre-operative positron emission tomography in gallbladder cancer. (2014) (34)
- Changes in the management of benign liver tumours: an analysis of 285 patients. (2013) (34)
- Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors (2019) (34)
- Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases (2017) (34)
- Regional Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Potential Role for Dynamic Magnetic Resonance Imaging as an Imaging Biomarker and a Survival Update from Two Prospective Clinical Trials (2014) (33)
- Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. (2012) (33)
- Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer (2012) (33)
- Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. (2019) (33)
- CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma (2019) (32)
- Clinical Features and Outcome of Primary Pancreatic Lymphoma (2015) (32)
- Pancreatic adenocarcinoma in a young patient population—12‐year experience at Memorial Sloan Kettering Cancer Center (2009) (32)
- Kinetics of liver volume changes in the first year after portal vein embolization. (2010) (32)
- Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection (2009) (32)
- The management of intraductal papillary mucinous neoplasms of the pancreas. (2010) (32)
- Regional differences in gallbladder cancer pathogenesis: Insights from a multi‐institutional comparison of tumor mutations (2018) (31)
- Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. (2020) (31)
- Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens (2015) (31)
- The role of surgery for patients with metastatic melanoma (2002) (30)
- Recurrence patterns following irreversible electroporation for hepatic malignancies (2017) (30)
- Synthesis, characterization, and functionalization of gold nanoparticles for cancer imaging. (2010) (29)
- Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. (2017) (29)
- Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer (2013) (29)
- Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors. (2019) (29)
- Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer. (2016) (29)
- Incidentally Discovered Pancreatic Intraepithelial Neoplasia: What Is Its Clinical Significance? (2013) (29)
- Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. (2016) (29)
- Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. (2014) (29)
- Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram. (2016) (28)
- Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease (2014) (28)
- Pancreatic metastasectomy: The Memorial Sloan‐Kettering experience and a review of the literature (2014) (28)
- Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing (2018) (27)
- Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer (2019) (27)
- Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation (2015) (27)
- RT-PCR Increases Detection of Submicroscopic Peritoneal Metastases in Gastric Cancer and Has Prognostic Significance (2011) (26)
- Segment and fit thresholding: a new method for image analysis applied to microarray and immunofluorescence data. (2015) (26)
- Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection* (2017) (25)
- Pitfalls in avoiding operation for autoimmune pancreatitis. (2011) (25)
- Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. (2014) (25)
- Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN) (2018) (24)
- A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas (2016) (24)
- Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy. (2010) (24)
- Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer. (2006) (24)
- Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas (2019) (23)
- Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report (2016) (22)
- A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients (2016) (22)
- 32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part One (2017) (22)
- Cystic Neoplasms of the Pancreas. (2016) (22)
- Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days? (2012) (22)
- Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas. (2010) (21)
- Hepatic Arterial Nodal Metastases in Pancreatic Cancer: Is This the Node of Importance? (2013) (21)
- Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. (2016) (21)
- Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies (2017) (20)
- Premalignant cystic neoplasms of the pancreas. (2015) (20)
- Detection of Micrometastases in Peritoneal Washings of Pancreatic Cancer Patients by the Reverse Transcriptase Polymerase Chain Reaction (2007) (20)
- Cystic lesions of the pancreas: Selection criteria for operative and non-operative management in 209 patients (2003) (20)
- Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges (2018) (20)
- Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism after Hepatectomy (2014) (20)
- Herpes Simplex Virus (HSV)-Mediated ICAM-1 Gene Transfer Abrogates Tumorigenicity and Induces Anti-Tumor Immunity (1999) (20)
- The effects of hepatic cryosurgery on tumor growth in the liver. (1998) (20)
- Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasms--also not harmless. (2014) (19)
- Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison. (2015) (19)
- Outcomes after Pancreatectomy with Routine Pasireotide Use. (2019) (19)
- High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy. (2011) (18)
- Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance ? luated at a Single Institution Results of 3024 Patients (2017) (18)
- Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (2013) (18)
- Surgical Treatment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Evans et al. (2009) (17)
- Histopathological growth patterns and positive margins after resection of colorectal liver metastases. (2018) (17)
- Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma (2007) (17)
- Prospective Evaluation of Laparoscopic Celiac Plexus Block in Patients with Unresectable Pancreatic Adenocarcinoma (2011) (17)
- Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2019) (16)
- Psychometric Validation of the EORTC QLQ-PAN26 Pancreatic Cancer Module for Assessing Health Related Quality of Life after Pancreatic Resection (2017) (16)
- Lower extremity lymphedema caused by acquired immune deficiency syndrome-related Kaposi's sarcoma: case report and review of the literature. (1995) (16)
- Saphenous vein versus polytetrafluoroethylene carotid patch angioplasty. (1997) (16)
- The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. (2017) (16)
- O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. (2017) (16)
- c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. (2013) (16)
- Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection (2016) (15)
- Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome (2014) (15)
- Hospital readmissions after liver surgery for metastatic colorectal cancer. (2015) (14)
- The management of cystic lesions of the pancreas. (2007) (14)
- Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase. (2017) (14)
- Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors (2021) (14)
- Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy. (2015) (14)
- Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. (2019) (13)
- The accuracy of pre-operative imaging in the management of hepatic cysts. (2015) (13)
- Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. (2019) (13)
- 3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial. (2017) (13)
- Uncinate Duct Dilation in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Radiographic Finding with Potentially Increased Malignant Potential (2014) (13)
- Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases (2020) (13)
- Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm. (2016) (12)
- Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach? (2019) (12)
- Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma (2021) (12)
- Pancreatic adenocarcinoma: putting a hump in survival. (2007) (12)
- Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience. (2016) (12)
- Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer (2016) (12)
- Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma (1998) (12)
- Operative drains after pancreatic resection--the Titanic is sinking. (2011) (12)
- The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma (2016) (12)
- The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made? (2019) (11)
- Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes (2018) (11)
- ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma. (2017) (11)
- Pasireotide for postoperative pancreatic fistula. (2014) (11)
- A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection. (2019) (11)
- Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. (2019) (11)
- Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer (2016) (11)
- Risk of Occult Irresectable Disease at Liver Resection for Hepatic Colorectal Cancer Metastases: A Contemporary Analysis (2013) (11)
- Therapeutic Approach to Cystic Neoplasms of the Pancreas. (2016) (11)
- Resolution of Hepatic Encephalopathy Following Hepatic Artery Embolization in a Patient with Well-Differentiated Neuroendocrine Tumor Metastatic to the Liver (2010) (11)
- Recurrence Patterns of Intraductal Papillary Mucinous Neoplasms of the Pancreas on Enhanced Computed Tomography (2009) (11)
- A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma (2018) (10)
- Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. (2019) (10)
- Use of Intraoperative Ablation as an Adjunct to Surgical Resection in the Treatment of Recurrent Colorectal Liver Metastases (2011) (10)
- Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA (2020) (10)
- Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease (2012) (10)
- Reply to Letter: "Operative Drainage Following Pancreatic Resections: We Need More Evidence". (2015) (10)
- Resection of perihilar biliary schwannoma. (2011) (10)
- Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype–Phenotype Features—An Entity With an Increasing Incidence? (2018) (9)
- Simple mucinous cysts of the pancreas have heterogeneous somatic mutations. (2020) (9)
- Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. (2018) (9)
- Pilot study of rapid MR pancreas screening for patients with BRCA mutation (2019) (9)
- Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases (2018) (9)
- Quantification of CT images for the classification of high- and low-risk pancreatic cysts (2017) (9)
- Is minimally invasive surgery of lesions in the right superior segments of the liver justified? A multi‐institutional study of 245 patients (2020) (8)
- O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. (2017) (8)
- Operative Resection is Currently Overutilized for Cystic Lesions of the Pancreas (2013) (8)
- Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study. (2020) (8)
- Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms (2020) (7)
- Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers (2012) (7)
- Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (7)
- Prognostic Significance of the Highest Peripancreatic Lymph Node in Biliary Tract Adenocarcinoma (2014) (7)
- Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. (2012) (7)
- The diagnosis and management of cystic lesions of the pancreas. (2017) (7)
- Evolving application of minimally invasive cancer operations at a tertiary cancer center (2017) (7)
- Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification. (2012) (7)
- Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center. (2011) (7)
- Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas (2017) (7)
- Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy (2020) (6)
- Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era (2016) (6)
- A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer. (2016) (6)
- Randomized clinical trials in pancreatic adenocarcinoma. (2010) (6)
- Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas (2017) (6)
- Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. (2013) (6)
- Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2 (2019) (6)
- Hepatic steatosis is associated with increased complications following major liver resection for cancer but does not impact survival (2003) (6)
- Texture analysis for survival prediction of pancreatic ductal adenocarcinoma patients with neoadjuvant chemotherapy (2016) (6)
- A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC). (2018) (6)
- Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms (2021) (6)
- 968 Performance Characteristics of Cyst Fluid CEA Analysis for the Diagnosis of Mucinous Cysts of the Pancreas (2009) (6)
- Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases (2018) (6)
- Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer (2021) (5)
- Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma? (2018) (5)
- Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases (2019) (5)
- Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (5)
- Malignant progression in intraductal papillary mucinous neoplasms of the pancreas: Results of 157 patients selected for radiographic surveillance. (2012) (5)
- MGMT immunohistochemistry (IHC) and exclusion of pancreatic NET (PanNET) patients from treatment with temozolomide-based therapy. (2014) (4)
- Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms (2016) (4)
- Pancreatic neuroendocrine tumors: Can the WHO staging system be simplified (2007) (4)
- T1377 Pancreatic Cyst Fluid CEA Concentration >1000 NG/Ml is Not an Indicator of Malignancy (2010) (4)
- Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement (2020) (4)
- Prospective assessment for pathogenic germline alterations (PGA) in pancreas cancer (PAC). (2017) (4)
- Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. (2015) (4)
- Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade. (2021) (4)
- Intraductal papillary neoplasm of the bile duct (IPNB): A biliary equivalent to IPMN of the pancreas? (2011) (4)
- Metastatic carcinoid tumour presenting as hepatic encephalopathy. (2002) (4)
- Postoperative liver failure risk score identifying patients with resectable perihilar cholangiocarcinoma who may benefit from portal vein embolization (2019) (3)
- Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT. (2016) (3)
- Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. (2020) (3)
- Right versus left: Impact of primary location on survival and cure in patients undergoing hepatic resection for metastatic colon cancer. (2017) (3)
- Advances in the management of pancreatic cystic neoplasms. (2020) (3)
- Prospective Phase II Trial of Combination Hepatic Artery and Systemic Chemotherapy for Unresectable Colorectal Liver Metastases: Long-Term Results and Curative Potential (2016) (3)
- Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? (2020) (3)
- Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery (2020) (3)
- Survival after resection plus intra-operative radiofrequency ablation (IRFA) to treat colorectal liver metastases (CLM): Results of an international collaborative study. (2013) (3)
- Studying cancer in minorities (2011) (3)
- Lending a hand for laparoscopic distal pancreatectomy: the optimal approach? (2019) (3)
- Levels of Evidence in Medical Research: "Bigger Is Not Always Better". (2017) (3)
- Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases. (2013) (2)
- Cystic Lesions of the Pancreas: Observe or Operate (2015) (2)
- 148 Biliary Self Expandable Metal Stents Do Not Increase Overall Complications in Patients Undergoing Pancreaticoduodenectomy (2012) (2)
- Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker (2020) (2)
- Chapter 66 – Techniques of pancreatic resection: Pancreaticoduodenectomy, distal pancreatectomy, segmental pancreatectomy, total pancreatectomy, and transduodenal resection of the papilla of vater (2017) (2)
- The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study (2017) (2)
- Treatment of pancreatic cancer by intra-arterial injection of an emulsion of Lipiodol and bumetanide (an anti-glycolytic drug) in a porcine model: initial results (2017) (2)
- Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence. (2011) (2)
- Improvement in long-term survival in patients with metastatic colorectal cancer (CRC) after liver resection with modern chemotherapy and hepatic arterial infusion (HAI). (2015) (2)
- Development of a preoperative risk score for postoperative mortality after liver resection for presumed perihilar cholangiocarcinoma (2016) (2)
- Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer: The Future Ain’t What It Used To Be (2011) (2)
- T1583 A Matched Case-Control Study of Preoperative Biliary Drainage (PDB) in Patients with Pancreatic Adenocarcinoma: Routine PBD Is Not Justified (2009) (2)
- Invasive central venous monitoring during hepatic resection: unnecessary for most patients. (2019) (2)
- Clinical outcomes in pancreatic adenocarcinoma (PAC) in breast cancer (BC) survivors. (2010) (2)
- Intensity-modulated radiation therapy (IMRT) in patients with locally advanced pancreatic cancer (LAPC). (2015) (2)
- Mutational profiling of resected intrahepatic cholangiocarcinoma. (2017) (2)
- Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas (2021) (2)
- Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies. (2014) (2)
- Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients (2020) (1)
- Merkel cell carcinoma : Improved outcome with the addition of adjuvant therapy. Authors' replay (2005) (1)
- Sa1466 Management of Peri-Pancreatic Fluid Collections Following Non-Whipple Pancreatic Surgery: A Comparison of Percutaneous vs EUS-Guided Drainage (2011) (1)
- FOLFIRINOX induction therapy for stage III pancreatic adenocarcinoma (2014) (1)
- Anatomy of the Pancreas and Biliary Tree (2018) (1)
- Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases. (2013) (1)
- 1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS (2019) (1)
- Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance. (2017) (1)
- Effect of perioperative complications on recurrence and survival after resection of hepatic colorectal metastases: Analysis of data from a randomized controlled trial. (2012) (1)
- Infiltrating neutrophils and malignant progression in intraductal papillary mucinous neoplasms (IPMN): An opportunity for identification of high-risk disease. (2014) (1)
- A Multicenter, Validation Study of Cyst Fluid Analysis for MAB Das-1 for the Identification of High-Risk and Malignant Mucinous Cysts of the Pancreas (2017) (1)
- Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype. (2016) (1)
- Clinical and Molecular Analysis of Adenosquamous Carcinoma of the Pancreas (2016) (1)
- Surgical Management of IPMN Lesions of the Pancreas (2015) (1)
- Chapter 57 – Cystic neoplasms of the pancreas: Epidemiology, clinical features, assessment, and management (2012) (1)
- Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM) (2012) (1)
- Chapter 60 - Cystic neoplasms of the pancreas: Epidemiology, clinical features, assessment, and management (2016) (1)
- Abstract A71: Studying cancer in minorities: A look at the numbers (2009) (1)
- Evolving Role of Drains, Tubes and Stents in Pancreatic Surgery (2018) (1)
- Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma (2021) (1)
- Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma. (2011) (1)
- A Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Grade Dysplasia in Intraductal Papillary Mucinous Neoplasms (2016) (1)
- Use of detailed pathologic characteristics of the primary colorectal tumor to predict outcome after hepatectomy for metastases. (2012) (1)
- A combined radiomics and cyst fluid inflammatory markers model to predict preoperative risk in pancreatic cystic lesions (2020) (1)
- Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results? (2011) (1)
- Reply to “Totally Laparoscopic Gastrectomy: A Reality for USA and Europe?” (ASO-2009-04-0501.R1) (2009) (1)
- Cancer Therapy : Preclinical Attenuation of the Retinoblastoma Pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk 4 / Cdk 6 (2012) (1)
- Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma (2021) (1)
- Quantitative CT analysis for the preoperative prediction of pathologic grade in pancreatic neuroendocrine tumors (2018) (1)
- Abstract 2444: The use of CT radiomics to predict immune infiltrate in pancreatic ductal adenocarcinoma (2019) (1)
- Biomarker Development in IPMN: The Problem of the Known Unknowns and the Unknown Unknowns. (2021) (1)
- Clinical outcomes in pancreatic adenocarcinoma (PAC) associated with a known BRCA mutation. (2011) (1)
- Fifty years of pancreas cancer care (2022) (1)
- Hepatocellular carcinoma in patients with no identifiable risk factors. (2019) (1)
- Endoscopic versus percutaneous drainage of post-operative fluid collection following pancreatic resection (2017) (1)
- Change in circulating tumor DNA after hepatic resection for metastatic colorectal cancer (2018) (1)
- Chemotherapy and Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer Achieves Prolonged Survival (2014) (1)
- Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Importance of biliary drainage of the future liver remnant and development of a risk score (2016) (1)
- 1031 Natural History of Patients Followed Radiographically With Mucinous Cystic Neoplasms of the Pancreas (2016) (0)
- Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics. (2017) (0)
- Recurrence Patterns after Irreversible Electroporation for Hepatic Metastases (2016) (0)
- Outcomes following transarterial embolization for hepatocellular carcinoma with complete radiologic response (2018) (0)
- Tu1217 Pancreatic Cyst Fluid Concentration of High-Mobility Group A2 (HMGA2) Protein Acts As a Differential Biomarker of Dysplasia in IPMN (2013) (0)
- T1915 Anti-Lewis Y Antibody As a Novel Target for Pancreatic Adenocarcinoma (2008) (0)
- AB098. P072. Investigation of BRCAness in pancreatic cancer using patient-derived organoid models (2018) (0)
- Patterns of recurrence and peri-operative predictors of liver metastasis after pancreatic cancer resection (2018) (0)
- ASO Visual Abstract: Recurrence After Resection of Pancreatic Cancer – Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? (2022) (0)
- Prospective analysis of somatic and germline genetic alterations in patients with ampullary carcinomas. (2018) (0)
- Clinical utility of immunoglobulin-G4 in the diagnosis of autoimmune pancreatitis (2017) (0)
- Su1530 Robotic Hepatic Artery Infusion Pump Placement (2016) (0)
- Significance of CEACAM6 expression in biliary tract carcinoma. (2012) (0)
- Association of adjuvant hepatic artery infusion chemotherapy after resection of colorectal liver metastases with improved survival in patients with both right- and left-sided primary tumors. (2018) (0)
- Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. (2017) (0)
- AB005. S005. A multiinstitutional postoperative nomogram for disease recurrence following resection of localized G1/G2 pancreatic neuroendocrine tumors (2018) (0)
- Pathology remains the most important predictor of long-term survival using a modern prognostic nomogram for resected pancreatic ductal adenocarcinoma (2019) (0)
- Outcomes after pancreatectomy with routine usage of pasireotide (2018) (0)
- When and How to Follow Patients with Cystic Tumors of the Pancreas (2016) (0)
- Pancreaticoduodenectomy for an acth-secreting pancreatic neuroendocrine tumor in a 12 year old: case report and literature review (2020) (0)
- Extraordinary survivorship after colorectal liver metastasis resection to identify a distinct molecular profile associated with survival in an independent cohort of 965 patients. (2017) (0)
- Empiric nasogastric decompression after pancreaticoduodenectomy is not necessary (2019) (0)
- Assessment of genomic alterations in adenosquamous carcinoma of the pancreas (ASCOP). (2016) (0)
- S1985 Pancreatic Cancer Patients From Lynch Syndrome-Like Families Do Not Have Improved Overall Survival When Compared With Sporadic Pancreatic Cancer Patients (2010) (0)
- How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? (2018) (0)
- Response to the Comment on "Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed Our Approach?: Results From a Multi-institutional Study". (2020) (0)
- Quality of life in RCT of pasireotide to reduce pancreatic complications following resection. (2015) (0)
- Intraductal Papillary Mucinous Neoplasm in Patients Under age 50: Tumor Biology, Clinical Features, Recurrence Rates, and Survival Outcomes (2017) (0)
- Incidence and risk factors for biliary sclerosis following adjuvant hepatic arterial infusion with floxuridine after hepatectomy for metastatic colorectal cancer. (2010) (0)
- A Prospective Cohort Study of a Perioperative Bundle to Reduce Surgical Site Infection following Pancreaticoduodenectomy (2021) (0)
- Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC). (2011) (0)
- T1462: EUS Impacts the Decision to Resect Small (≤ 3 cm), Asymptomatic Pancreatic Cystic Lesions (2010) (0)
- Genomic landscape of pancreatic adenocarcinoma: Does age matter? (2016) (0)
- Attenuation of the Rb pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk 4 / Cdk 6 (2012) (0)
- W1668 The use of Intraoperative Ablation Extends the Limits of Potentially Curative Treatment for Recurrent Colorectal Liver Metastases (2010) (0)
- Improved mortality after pancreatectomy in the modern era (2018) (0)
- 597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts (2016) (0)
- Iconographies supplémentaires de l'article : FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis (2016) (0)
- A matched analysis comparing the epidemiology of intraductal papillary mucinous neoplasms to standard pancreatic adenocarcinoma and healthy controls. (2011) (0)
- Cystic tumors of the pancreas (2010) (0)
- M1289 Family History of Certain Cancers Is Not Associated with Younger Age At Diagnosis of Pancreatic Adenocarcinoma (2009) (0)
- Cystic Neoplasms of the Pancreas: Diagnosis and imaging (2009) (0)
- Gene expression profiles to predict outcome following liver resection in patients with metastasis of colorectal cancer. (2010) (0)
- 488 Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection vs. Observation (2015) (0)
- Role of biliary CEACAM6 as a biomarker for cholangiocarcinoma. (2013) (0)
- – BONE AND SOFT TISSUE SARCOMAS Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor (2019) (0)
- Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients (2018) (0)
- Minimally invasive versus open segment 7 and 8 hepatic resection: a propensity score-matched comparison (2017) (0)
- The management of small asymptomatic pancreatic neuroendocrine tumors: A matched case-control study. (2015) (0)
- 160. Cyst Fluid Protein Expression Profiling for the Discrimination Between Benign and Premalignant Cysts of the Pancreas (2008) (0)
- Robotic completion radical cholecystectomy for incidental gallbladder cancer (2020) (0)
- Conversion to complete surgical treatment using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer. (2012) (0)
- Internal Hernia After Gastrectomy With Roux-Y Reconstruction for Cancer (2013) (0)
- Use of CXCR4 as a prognostic marker for disease-specific survival and pattern of recurrence following resection of hepatic colorectal metastases. (2009) (0)
- Empiric nasogastric decompression after pancreaticoduodenectomy is not necessary. (2021) (0)
- Trans-arterial embolization for hepatocellular carcinoma: doxorubicin is not necessary (2016) (0)
- Long-termOutcomes Following Tumor Ablation for Treatment of Bilateral Colorectal LiverMetastases (2013) (0)
- ASO Author Reflections: Long-Term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma (2021) (0)
- Health-related quality of life (HRQoL) following pancreatic resection in RCT of pasireotide. (2014) (0)
- Symptomatic perihepatic collections after hepatic resection in the modern era (2014) (0)
- Non-alcoholic fatty liver disease is an independent predictor of recurrence after resection of colorectal liver metastases (2019) (0)
- Chapter 25 – Postoperative complications requiring intervention, diagnosis, and management (2012) (0)
- Cancer of the Pancreas: Distal Resections and Staging of Pancreatic Cancer (2011) (0)
- Recurrence rate and pattern after resection of colorectal liver metastases with and without hepatic arterial infusion chemotherapy (2018) (0)
- 913 Pharmacologic Prophylaxis, Postoperative INR, and Risk of Venous Thromboembolism After Hepatectomy (2013) (0)
- M1386 Azathioprine is Effective in Maintaining Clinical, Radiographic, and Biochemical Remission in Autoimmune Pancreatitis/IgG4-Associated Cholangitis (2010) (0)
- Abstract B60: Analysis of the endocytic receptor MRC2 as a target for mesenchymal pancreatic cancer cells (2013) (0)
- Pancreatic adenocarcinoma (PAC) in a younger patient population: 10-year experience at Memorial Sloan-Kettering Cancer Center (MSKCC) (2008) (0)
- Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Associated PDAC (2021) (0)
- Regional differences in gallbladder cancer pathogenesis: Insights from a comparison of tumor mutations (2018) (0)
- Resection of colorectal liver metastases after early failure of adjuvant systemic chemotherapy for the primary tumor: Is there a role for additional treatment (2018) (0)
- Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer Achieves High Rate of R0 Resection (2011) (0)
- Hepatic arterial infusion for unresectable intrahepatic cholangiocarcinoma: An update on survival from two prospective clinical trials. (2013) (0)
- Abstract PO-002: Detection of chemotherapy-resistant pancreatic cancer using a glycan Biomarker (2020) (0)
- Postoperative complications and extended hospitalization impact timely initiation and completion of adjuvant therapy for pancreas cancer (2019) (0)
- Adjuvant hepatic arterial infusion chemotherapy is associated with superior survival after resection of colorectal liver metastases: A propensity score analysis of 2368 patients (2016) (0)
- Poor prognosis in patients with resectable KRAS-MUT colorectal liver metastases is improved by adjuvant hepatic arterial infusion chemotherapy. (2017) (0)
- Sa1487 Direct Percutaneous Endoscopic Jejunostomy for Management of Severe Delayed Gastric Emptying Following Pancreatoduodenectomy (2015) (0)
- A multicentre analysis on the impact of primary tumour location in patients undergoing surgery for colorectal liver metastasis. (2019) (0)
- Adequate lymph node assessment for extrahepatic bile duct cancer: Do the data support the current AJCC recommendations? (2009) (0)
- Recurrence rate and patterns with and without perioperative systemic chemotherapy after resection of colorectal liver metastases (2018) (0)
- Abstract 4555: Protein and glycan biomarkers of malignant potential in pancreatic cyst fluid (2012) (0)
- 1028 Management of Symptomatic Intraabdominal Collections After 672 Hepatic Resections (2009) (0)
- Multidisciplinary, perioperative care bundle decreases surgical site infection in patients undergoing synchronous colorectal/liver resection (2018) (0)
- Behind the cyst: predicting grade of dysplasia in intraductal papillary mucinous neoplasms (IPMNs) by quantitative image analysis (2017) (0)
- Intraductal papillary mucinous neoplasms in young patients have different epithelial subtypes and a more favorable prognosis (2017) (0)
- Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage. (2023) (0)
- Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome (2014) (0)
- Longitudinal follow-up of a prospective phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma reveals distinct patterns of survivorship (2019) (0)
- KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma. (2019) (0)
- Proteomic evaluation of biliary exosomes implicates exportin7 in the pathogenesis of extrahepatic cholangiocarcinoma (2017) (0)
- Vascular inflow control during hepatic lobectomy: a comparison of intrahepatic pedicle ligation versus extrahepatic ligation (2003) (0)
- ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter J. Allen?
Peter J. Allen is affiliated with the following schools: